Calpains and cardiac diseases;Les calpaïnes : Implication en pathologie cardiaque

Annales de Cardiologie et d'Angeiologie

Volumn 53, Issue 5, 2004, Pages 259-266

  Perrin, C ^a   Vergely, C ^a   Rochette, L ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Atrial fibrillation; Calpains; Calpa nes; Cardiac diseases; Fibrillation auriculaire; Heart failure; Insuffisance cardiaque; Ischemia reperfusion; Isch mie reperfusion; Pathologies cardiaques

Indexed keywords

CALCIUM; CALPAIN; CALPASTATIN; CYSTEINE PROTEINASE; ISOENZYME; PHOSPHOLIPID; STRUCTURAL PROTEIN; TROPONIN;

APOPTOSIS; AUTOLYSIS; CELL DEATH; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 4444351214     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ancard.2004.05.004     Document Type: Short Survey

References (47)

1. Guroff G., Guroff G. A neutral calcium-activated proteinase from the soluble fraction of rat brain. J. Biol. Chem. 239:1964;149
2. Ishiura S., et al. Studies of calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization. J. Biol. Chem. 84:1978;225-230
3. Huang Y., Wang K.K. The calpain family and human disease. Trends Mol Med. 7:(8):2001;355-362
4. Reverter D., et al. Structural basis for possible calcium-induced activation mechanisms of calpains. Biol Chem. 382:(5):2001;753-766
5. Carafoli E., Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commun. 247:(2):1998;193-203
6. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev. 71:(3):1991;813-847
7. Molinari M., Carafoli E. Calpain: a cytosolic proteinase active at the membranes. J Membr Biol. 156:(1):1997;1-8
8. Kawasaki H., Kawashima S. Regulation of the calpain-calpastatin system by membranes (review). Mol Membr Biol. 13:(4):1996;217-224
9. Perrin B.J., Huttenlocher A. Calpain. Int J Biochem Cell Biol. 34:(7):2002;722-725
10. Saido T.C., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological- pathological involvement. Faseb J. 8:(11):1994;814-822
11. Shore A.C., et al. Association of calpain-10 gene with microvascular function. Diabetologia. 45:(6):2002;899-904
12. Van Der Laarse A. Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure. Cardiovasc Res. 56:(1):2002;8-14
13. Cicilini M.A., et al. Calpain activity of hypertrophic hearts from hypertensive rats. Braz J Med Biol Res. 28:(6):1995;621-625
14. Arthur G.D., Belcastro A.N. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem. 176:(1-2):1997;241-248
15. Papp Z., Van Der Velden J., Stienen G.J. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart [see comments]. Cardiovasc Res. 45:(4):2000;981-993
16. Gorza L., et al. Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. Circulation. 93:(10):1996;1896-1904
17. Gao W.D., et al. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 80:(3):1997;393-399
18. Brundel B.J., et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res. 54:(2):2002;380-389
19. Goette A., et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol. 283:(1):2002;H264-H272
20. Vergely C., et al. Postischemic recovery and oxidative stress are independent of nitric-oxide synthases modulation in isolated rat heart. J Pharmacol Exp Ther. 303:(1):2002;149-157
21. Kawashima S., et al. Tissue distribution of calcium-activated neutral proteinases in rat. Biochim Biophys Acta. 965:(2-3):1988;130-135
22. Kunimatsu M., et al. Activation of calpain in myocardial infarction: an immunohistochemical study using a calpain antibody raised against active site histidine- containing peptide. Cardiovasc Pathol. 8:(1):1999;7-15
23. Yoshida K., Yamasaki Y., Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion. Biochim Biophys Acta. 1182:(2):1993;215-220
24. Sorimachi Y., et al. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion. J Biochem (Tokyo). 122:(4):1997;743-748
25. Chen M., et al. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia-reperfusion. J Biol Chem. 276:(33):2001;30724- 30728
26. Iizuka K., Kawaguchi H., Kitabatake A. Effects of thiol protease inhibitors on fodrin degradation during hypoxia in cultured myocytes. J Mol Cell Cardiol. 25:(9):1993;1101-1109
27. Atsma D.E., et al. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ Res. 76:(6):1995;1071-1078
28. Chen S.J., Bradley M.E., Lee T.C. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: modulation by calcium-regulated proteases and protein kinases. Mol Cell Biochem. 178:(1-2):1998;141-149
29. Kositprapa C., et al. Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem. 214:(1-2):2000;47-55
30. Sandmann S., et al. Activity profile of calpains I and II in chronically infarcted rat myocardium-influence of the calpain inhibitor CAL 9961. Br J Pharmacol. 135:(8):2002;1951-1958
31. 2+-dependent proteolysis? Circ Res. 78:(3):1996;455-465
32. Matsumura Y., et al. Protective effect of the protease inhibitor leupeptin against myocardial stunning. J Cardiovasc Pharmacol. 22:(1):1993;135-142
33. Yoshida K., et al. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain. Circ Res. 77:(3):1995;603-610
34. Urthaler F., et al. MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc Res. 35:(1):1997;60-67
35. Kakkar R., et al. Decreased expression of high-molecular-weight calmodulin-binding protein and its correlation with apoptosis in ischemia-reperfused rat heart. Cell Calcium. 29:(1):2001;59-71
36. Ikeda Y., Young L.H., Lefer A.M. Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor. Am J Physiol Heart Circ Physiol. 282:(4):2002;H1421-H1426
37. Matsumura Y., et al. Inhomogeneous disappearance of myofilament-related cytoskeletal proteins in stunned myocardium of guinea pig. Circ Res. 79:(3):1996;447-454
38. Toyo-oka T., et al. Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitorr, NCO-700, against calcium-activated neutral protease. Jpn Heart J. 23:(5):1982;829-834
39. Iwamoto H., et al. Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemic-reperfused rat heart. J Cardiovasc Pharmacol. 33:(4):1999;580-586
40. Chen M., et al. Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem. 277:(32):2002;29181-29186
41. Squier M.K., et al. Calpain activation in apoptosis. J Cell Physiol. 159:(2):1994;229-237
42. Sindram D., et al. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. Transplantation. 68:(1):1999;136-140
43. Ruiz-Vela A., Gonzalez de Buitrago G., Martinez A.C. Implication of calpain in caspase activation during B cell clonal deletion. Embo J. 18:(18):1999;4988-4998
44. Squier M.K., et al. Calpain and calpastatin regulate neutrophil apoptosis. J Cell Physiol. 178:(3):1999;311-319
45. Lu T., et al. Participation of the conventional calpains in apoptosis. Biochim Biophys Acta. 1590:(1-3):2002;16-26
46. Perrin C., et al. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Cell Mol Biol (Noisy-le-grand). 49:2003;OL497-OL505. Online Pub
47. Perrin C., et al. In vitro antioxidant properties of calpain inhibitors: leupeptin and calpain inhibitor-1. Cell Mol Biol (Noisy-le-grand). 48:2002;OL267-OL270. (Online Pub)